Works matching IS 18696953 AND DT 2018 AND VI 9 AND IP 3
Results: 41
Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1335, doi. 10.1007/s13300-018-0444-y
- By:
- Publication type:
- Article
Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1307, doi. 10.1007/s13300-018-0441-1
- By:
- Publication type:
- Article
Thoughts, Words, Action: The Alma-Ata Declaration to Diabetes Care Transformation.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 873, doi. 10.1007/s13300-018-0440-2
- By:
- Publication type:
- Article
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1317, doi. 10.1007/s13300-018-0439-8
- By:
- Publication type:
- Article
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1369, doi. 10.1007/s13300-018-0438-9
- By:
- Publication type:
- Article
Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1403, doi. 10.1007/s13300-018-0437-x
- By:
- Publication type:
- Article
Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1269, doi. 10.1007/s13300-018-0436-y
- By:
- Publication type:
- Article
The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case-Control Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1295, doi. 10.1007/s13300-018-0435-z
- By:
- Publication type:
- Article
Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1359, doi. 10.1007/s13300-018-0433-1
- By:
- Publication type:
- Article
Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1279, doi. 10.1007/s13300-018-0432-2
- By:
- Publication type:
- Article
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1185, doi. 10.1007/s13300-018-0431-3
- By:
- Publication type:
- Article
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UK.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1217, doi. 10.1007/s13300-018-0430-4
- By:
- Publication type:
- Article
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1149, doi. 10.1007/s13300-018-0424-2
- By:
- Publication type:
- Article
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1233, doi. 10.1007/s13300-018-0428-y
- By:
- Publication type:
- Article
A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1143, doi. 10.1007/s13300-018-0427-z
- By:
- Publication type:
- Article
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1201, doi. 10.1007/s13300-018-0426-0
- By:
- Publication type:
- Article
Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1113, doi. 10.1007/s13300-018-0425-1
- By:
- Publication type:
- Article
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1169, doi. 10.1007/s13300-018-0429-x
- By:
- Publication type:
- Article
Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 927, doi. 10.1007/s13300-018-0422-4
- By:
- Publication type:
- Article
Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1099, doi. 10.1007/s13300-018-0421-5
- By:
- Publication type:
- Article
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 919, doi. 10.1007/s13300-018-0420-6
- By:
- Publication type:
- Article
Basal-Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1049, doi. 10.1007/s13300-018-0419-z
- By:
- Publication type:
- Article
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1347, doi. 10.1007/s13300-018-0413-5
- By:
- Publication type:
- Article
Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a “Chicken and Egg” Paradigm in Ketosis-Prone Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1377, doi. 10.1007/s13300-018-0417-1
- By:
- Publication type:
- Article
Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1083, doi. 10.1007/s13300-018-0416-2
- By:
- Publication type:
- Article
Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1061, doi. 10.1007/s13300-018-0415-3
- By:
- Publication type:
- Article
Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1001, doi. 10.1007/s13300-018-0414-4
- By:
- Publication type:
- Article
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1037, doi. 10.1007/s13300-018-0418-0
- By:
- Publication type:
- Article
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1253, doi. 10.1007/s13300-018-0412-6
- By:
- Publication type:
- Article
Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 891, doi. 10.1007/s13300-018-0411-7
- By:
- Publication type:
- Article
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1021, doi. 10.1007/s13300-018-0410-8
- By:
- Publication type:
- Article
A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1073, doi. 10.1007/s13300-018-0409-1
- By:
- Publication type:
- Article
Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1125, doi. 10.1007/s13300-018-0407-3
- By:
- Publication type:
- Article
The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 963, doi. 10.1007/s13300-018-0404-6
- By:
- Publication type:
- Article
Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 987, doi. 10.1007/s13300-018-0403-7
- By:
- Publication type:
- Article
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 951, doi. 10.1007/s13300-018-0402-8
- By:
- Publication type:
- Article
A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 973, doi. 10.1007/s13300-018-0397-1
- By:
- Publication type:
- Article
Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 877, doi. 10.1007/s13300-018-0395-3
- By:
- Publication type:
- Article
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1397, doi. 10.1007/s13300-018-0390-8
- By:
- Publication type:
- Article